{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T10:27:57Z","timestamp":1792578477372,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"8040","license":[{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T00:00:00Z","timestamp":1729036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2024,11,28]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Toxic epidermal necrolysis (TEN) is a fatal drug-induced skin reaction triggered by common medications and is an emerging public health issue<jats:sup>1\u20133<\/jats:sup>. Patients with TEN undergo severe and sudden epidermal detachment caused by keratinocyte cell death. Although molecular mechanisms that drive keratinocyte cell death have been proposed, the main drivers remain unknown, and there is no effective therapy for TEN<jats:sup>4\u20136<\/jats:sup>. Here, to systematically map molecular changes that are associated with TEN and identify potential druggable targets, we utilized deep visual proteomics, which provides single-cell-based, cell-type-resolution proteomics<jats:sup>7,8<\/jats:sup>. We analysed formalin-fixed, paraffin-embedded archived skin tissue biopsies of three types of cutaneous drug reactions with varying severity and quantified more than 5,000 proteins in keratinocytes and skin-infiltrating immune cells. This revealed a marked enrichment of type I and type II interferon signatures in the immune cell and keratinocyte compartment of patients with TEN, as well as phosphorylated STAT1 activation. Targeted inhibition with the pan-JAK inhibitor tofacitinib in vitro reduced keratinocyte-directed cytotoxicity. In vivo oral administration of tofacitinib, baricitinib or the JAK1-specific inhibitors abrocitinib or upadacitinib ameliorated clinical and histological disease severity in two distinct mouse models of TEN. Crucially, treatment with JAK inhibitors (JAKi) was safe and associated with rapid cutaneous re-epithelialization and recovery in seven patients with TEN. This study uncovers the JAK\/STAT and interferon signalling pathways as key pathogenic drivers of TEN and demonstrates the potential of targeted JAKi as a curative therapy.<\/jats:p>","DOI":"10.1038\/s41586-024-08061-0","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T16:03:44Z","timestamp":1729094624000},"page":"1001-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":155,"title":["Spatial proteomics identifies JAKi as treatment for a lethal skin disease"],"prefix":"10.1038","volume":"635","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3702-815X","authenticated-orcid":false,"given":"Thierry M.","family":"Nordmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3913-9686","authenticated-orcid":false,"given":"Holly","family":"Anderton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akito","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Schweizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia-Charlotte","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1043-6591","authenticated-orcid":false,"given":"Andreas","family":"Metousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4604-6170","authenticated-orcid":false,"given":"Florian A.","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-5619","authenticated-orcid":false,"given":"Maximilian","family":"Zwiebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-9253","authenticated-orcid":false,"given":"Takashi K.","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Anzengruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian T.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Tanzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-2221","authenticated-orcid":false,"given":"Marvin","family":"Thielert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-3442","authenticated-orcid":false,"given":"Haruna","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Silke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin H.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4364-2364","authenticated-orcid":false,"given":"Gaetana","family":"Restivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Ha","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4858-5525","authenticated-orcid":false,"given":"Laurence","family":"Feldmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Joerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5902-9420","authenticated-orcid":false,"given":"Mitchell P.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6329-9802","authenticated-orcid":false,"given":"Peter J.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7843-5341","authenticated-orcid":false,"given":"Andreas","family":"Mund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-5774","authenticated-orcid":false,"given":"John","family":"Silke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2282-3505","authenticated-orcid":false,"given":"Chao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4629-1486","authenticated-orcid":false,"given":"Lars E.","family":"French","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1292-4799","authenticated-orcid":false,"given":"Matthias","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,16]]},"reference":[{"key":"8061_CR1","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3390\/ijms17122135","volume":"17","author":"V Harris","year":"2016","unstructured":"Harris, V., Jackson, C. & Cooper, A. Review of toxic epidermal necrolysis. Int. J. Mol. Sci. 17, 2135 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"8061_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula, P. et al. Comprehensive survival analysis of a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. J. Invest. Dermatol. 133, 1197\u20131204 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"8061_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou, J., Pomeranz, B. H. & Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 279, 1200\u20131205 (1998).","journal-title":"JAMA"},{"key":"8061_CR4","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jaad.2011.09.029","volume":"66","author":"A Downey","year":"2012","unstructured":"Downey, A., Jackson, C., Harun, N. & Cooper, A. Toxic epidermal necrolysis: review of pathogenesis and management. J. Am. Acad. Dermatol. 66, 995\u20131003 (2012).","journal-title":"J. Am. Acad. Dermatol."},{"key":"8061_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.12688\/f1000research.7574.1","volume":"5","author":"W Hoetzenecker","year":"2016","unstructured":"Hoetzenecker, W. et al. Toxic epidermal necrolysis. F1000Research 5, 951 (2016).","journal-title":"F1000Research"},{"key":"8061_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","volume":"98","author":"WC Chang","year":"2020","unstructured":"Chang, W. C. et al. SJS\/TEN 2019: From science to translation. J. Dermatol. Sci. 98, 2\u201312 (2020).","journal-title":"J. Dermatol. Sci."},{"key":"8061_CR7","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/s41587-022-01302-5","volume":"40","author":"A Mund","year":"2022","unstructured":"Mund, A. et al. Deep Visual Proteomics defines single-cell identity and heterogeneity. Nat. Biotechnol. 40, 1231\u20131240 (2022).","journal-title":"Nat. Biotechnol."},{"key":"8061_CR8","doi-asserted-by":"crossref","unstructured":"Rosenberger, F. A. et al. Spatial single-cell mass spectrometry defines zonation of the hepatocyte proteome. Nat. Methods 20, 1530\u20131536(2023).","DOI":"10.1038\/s41592-023-02007-6"},{"key":"8061_CR9","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1111\/bcp.15490","volume":"90","author":"BR Del Pozzo-Magana","year":"2024","unstructured":"Del Pozzo-Magana, B. R. & Liy-Wong, C. Drugs and the skin: a concise review of cutaneous adverse drug reactions. Br. J. Clin. Pharmacol. 90, 1838\u20131855 (2024).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"8061_CR10","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung, S. I. et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc. Natl Acad. Sci. USA 102, 4134\u20134139 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8061_CR11","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","volume":"7","author":"WH Chung","year":"2007","unstructured":"Chung, W. H., Hung, S. I. & Chen, Y. T. Human leukocyte antigens and drug hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 7, 317\u2013323 (2007).","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"8061_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung, W. H. et al. Medical genetics: a marker for Stevens\u2013Johnson syndrome. Nature 428, 486 (2004).","journal-title":"Nature"},{"key":"8061_CR13","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","volume":"128","author":"TM Ko","year":"2011","unstructured":"Ko, T. M. et al. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens\u2013Johnson syndrome. J. Allergy Clin. Immunol. 128, 1266\u20131276.e1211 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"8061_CR14","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","volume":"114","author":"A Nassif","year":"2004","unstructured":"Nassif, A. et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J. Allergy Clin. Immunol. 114, 1209\u20131215 (2004).","journal-title":"J. Allergy Clin. Immunol."},{"key":"8061_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","volume":"119","author":"L Le Cleach","year":"2000","unstructured":"Le Cleach, L. et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin. Exp. Immunol. 119, 225\u2013230 (2000).","journal-title":"Clin. Exp. Immunol."},{"key":"8061_CR16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/archderm.1994.01690050066011","volume":"130","author":"PS Friedmann","year":"1994","unstructured":"Friedmann, P. S., Strickland, I., Pirmohamed, M. & Park, B. K. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch. Dermatol. 130, 598\u2013604 (1994).","journal-title":"Arch. Dermatol."},{"key":"8061_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1001\/archderm.1992.01680110060006","volume":"128","author":"G Villada","year":"1992","unstructured":"Villada, G., Roujeau, J. C., Clerici, T., Bourgault, I. & Revuz, J. Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch. Dermatol. 128, 50\u201353 (1992).","journal-title":"Arch. Dermatol."},{"key":"8061_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S0190-9622(08)80969-3","volume":"25","author":"MC Heng","year":"1991","unstructured":"Heng, M. C. & Allen, S. G. Efficacy of cyclophosphamide in toxic epidermal necrolysis. Clinical and pathophysiologic aspects. J. Am. Acad. Dermatol. 25, 778\u2013786 (1991).","journal-title":"J. Am. Acad. Dermatol."},{"key":"8061_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1001\/archderm.1993.01680250078010","volume":"129","author":"O Correia","year":"1993","unstructured":"Correia, O., Delgado, L., Ramos, J. P., Resende, C. & Torrinha, J. A. Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. Arch. Dermatol. 129, 466\u2013468 (1993).","journal-title":"Arch. Dermatol."},{"key":"8061_CR20","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard, I. et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282, 490\u2013493 (1998).","journal-title":"Science"},{"key":"8061_CR21","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","volume":"134","author":"C Paul","year":"1996","unstructured":"Paul, C. et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br. J. Dermatol. 134, 710\u2013714 (1996).","journal-title":"Br. J. Dermatol."},{"key":"8061_CR22","doi-asserted-by":"publisher","first-page":"245ra295","DOI":"10.1126\/scitranslmed.3008227","volume":"6","author":"N Saito","year":"2014","unstructured":"Saito, N. et al. An annexin A1-FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions. Sci. Transl. Med. 6, 245ra295 (2014).","journal-title":"Sci. Transl. Med."},{"key":"8061_CR23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/jid.2012.330","volume":"133","author":"I Viard-Leveugle","year":"2013","unstructured":"Viard-Leveugle, I. et al. TNF-alpha and IFN-gamma are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis. J. Invest. Dermatol. 133, 489\u2013498 (2013).","journal-title":"J. Invest. Dermatol."},{"key":"8061_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung, W. H. et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Nat. Med. 14, 1343\u20131350 (2008).","journal-title":"Nat. Med."},{"key":"8061_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/bjd.19893","volume":"185","author":"MC Bruggen","year":"2021","unstructured":"Bruggen, M. C. et al. Supportive care in the acute phase of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus. Br. J. Dermatol. 185, 616\u2013626 (2021).","journal-title":"Br. J. Dermatol."},{"key":"8061_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41576-023-00580-2","volume":"24","author":"K Vandereyken","year":"2023","unstructured":"Vandereyken, K., Sifrim, A., Thienpont, B. & Voet, T. Methods and applications for single-cell and spatial multi-omics. Nat. Rev. Genet. 24, 494\u2013515 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"8061_CR27","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.molcel.2022.05.022","volume":"82","author":"A Mund","year":"2022","unstructured":"Mund, A., Brunner, A. D. & Mann, M. Unbiased spatial proteomics with single-cell resolution in tissues. Mol. Cell 82, 2335\u20132349 (2022).","journal-title":"Mol. Cell"},{"key":"8061_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1006\/cyto.1995.1009","volume":"7","author":"J Fleckner","year":"1995","unstructured":"Fleckner, J., Martensen, P. M., Tolstrup, A. B., Kjeldgaard, N. O. & Justesen, J. Differential regulation of the human, interferon inducible tryptophanyl-tRNA synthetase by various cytokines in cell lines. Cytokine 7, 70\u201377 (1995).","journal-title":"Cytokine"},{"key":"8061_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1046\/j.1523-1747.2000.00816.x","volume":"114","author":"LH Lerner","year":"2000","unstructured":"Lerner, L. H., Qureshi, A. A., Reddy, B. V. & Lerner, E. A. Nitric oxide synthase in toxic epidermal necrolysis and Stevens\u2013Johnson syndrome. J. Invest. Dermatol. 114, 196\u2013199 (2000).","journal-title":"J. Invest. Dermatol."},{"key":"8061_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1001\/archderm.141.6.683","volume":"141","author":"AM Quinn","year":"2005","unstructured":"Quinn, A. M. et al. Uncovering histologic criteria with prognostic significance in toxic epidermal necrolysis. Arch. Dermatol. 141, 683\u2013687 (2005).","journal-title":"Arch. Dermatol."},{"key":"8061_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41591-019-0733-7","volume":"26","author":"D Kim","year":"2020","unstructured":"Kim, D. et al. Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report. Nat. Med. 26, 236\u2013243 (2020).","journal-title":"Nat. Med."},{"key":"8061_CR32","doi-asserted-by":"publisher","first-page":"10085","DOI":"10.1073\/pnas.181347998","volume":"98","author":"B Chaudhuri","year":"2001","unstructured":"Chaudhuri, B., Xu, H., Todorov, I., Dutta, A. & Yates, J. L. Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein\u2013Barr virus. Proc. Natl Acad. Sci. USA 98, 10085\u201310089 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8061_CR33","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202211503","volume":"19","author":"M Thielert","year":"2023","unstructured":"Thielert, M. et al. Robust dimethyl-based multiplex-DIA doubles single-cell proteome depth via a reference channel. Mol. Syst. Biol. 19, e11503 (2023).","journal-title":"Mol. Syst. Biol."},{"key":"8061_CR34","doi-asserted-by":"publisher","unstructured":"Guzman, U. H. et al. Ultra-fast label-free quantification and comprehensive proteome coverage with narrow-window data-independent acquisition. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-023-02099-7 (2024).","DOI":"10.1038\/s41587-023-02099-7"},{"key":"8061_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nri3743","volume":"14","author":"A Linkermann","year":"2014","unstructured":"Linkermann, A., Stockwell, B. R., Krautwald, S. & Anders, H. J. Regulated cell death and inflammation: an auto-amplification loop causes organ failure. Nat. Rev. Immunol. 14, 759\u2013767 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"8061_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1101\/gad.2.4.383","volume":"2","author":"DE Levy","year":"1988","unstructured":"Levy, D. E., Kessler, D. S., Pine, R., Reich, N. & Darnell, J. E. Jr. Interferon-induced nuclear factors that bind a shared promoter element correlate with positive and negative transcriptional control. Genes Dev. 2, 383\u2013393 (1988).","journal-title":"Genes Dev."},{"key":"8061_CR37","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1084\/jem.20182031","volume":"216","author":"K Tretina","year":"2019","unstructured":"Tretina, K., Park, E. S., Maminska, A. & MacMicking, J. D. Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease. J. Exp. Med. 216, 482\u2013500 (2019).","journal-title":"J. Exp. Med."},{"key":"8061_CR38","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s12276-022-00765-5","volume":"54","author":"Y Sung","year":"2022","unstructured":"Sung, Y., Yoon, I., Han, J. M. & Kim, S. Functional and pathologic association of aminoacyl-tRNA synthetases with cancer. Exp. Mol. Med. 54, 553\u2013566 (2022).","journal-title":"Exp. Mol. Med."},{"key":"8061_CR39","first-page":"402","volume":"69","author":"CE Lewis","year":"1990","unstructured":"Lewis, C. E., McCarthy, S. P., Lorenzen, J. & McGee, J. O. Differential effects of LPS, IFN-gamma and TNF alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity. Immunology 69, 402\u2013408 (1990).","journal-title":"Immunology"},{"key":"8061_CR40","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jcp.22345","volume":"226","author":"W Liao","year":"2011","unstructured":"Liao, W. et al. A novel anti-apoptotic role for apolipoprotein L2 in IFN-gamma-induced cytotoxicity in human bronchial epithelial cells. J. Cell. Physiol. 226, 397\u2013406 (2011).","journal-title":"J. Cell. Physiol."},{"key":"8061_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-018-0199-6","volume":"8","author":"F Wang","year":"2018","unstructured":"Wang, F. et al. Diverse expression of TNF-alpha and CCL27 in serum and blister of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis. Clin. Transl. Allergy 8, 12 (2018).","journal-title":"Clin. Transl. Allergy"},{"key":"8061_CR42","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.3390\/cells11121955","volume":"11","author":"LS Wustner","year":"2022","unstructured":"Wustner, L. S. Generating iPSCs with a high-efficient, non-invasive method-an improved way to cultivate keratinocytes from plucked hair for reprogramming. Cells 11, 1955 (2022).","journal-title":"Cells"},{"key":"8061_CR43","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/j.jid.2017.05.031","volume":"137","author":"H Anderton","year":"2017","unstructured":"Anderton, H., Rickard, J. A., Varigos, G. A., Lalaoui, N. & Silke, J. Inhibitor of apoptosis proteins (IAPs) limit RIPK1-mediated skin inflammation. J. Invest. Dermatol. 137, 2371\u20132379 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"8061_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jaci.2012.09.014","volume":"131","author":"N Saito","year":"2013","unstructured":"Saito, N. et al. Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients. J. Allergy Clin. Immunol. 131, 434\u2013441 e431-439 (2013).","journal-title":"J. Allergy Clin. Immunol."},{"key":"8061_CR45","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","volume":"131","author":"E Varfolomeev","year":"2007","unstructured":"Varfolomeev, E. et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669\u2013681 (2007).","journal-title":"Cell"},{"key":"8061_CR46","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/icb.2016.118","volume":"95","author":"L Vasilikos","year":"2017","unstructured":"Vasilikos, L., Spilgies, L. M., Knop, J. & Wong, W. W. Regulating the balance between necroptosis, apoptosis and inflammation by inhibitors of apoptosis proteins. Immunol. Cell Biol. 95, 160\u2013165 (2017).","journal-title":"Immunol. Cell Biol."},{"key":"8061_CR47","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.jdermsci.2012.04.002","volume":"66","author":"WH Chung","year":"2012","unstructured":"Chung, W. H. & Hung, S. I. Recent advances in the genetics and immunology of Stevens\u2013Johnson syndrome and toxic epidermal necrosis. J. Dermatol. Sci. 66, 190\u2013196 (2012).","journal-title":"J. Dermatol. Sci."},{"key":"8061_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin, S. et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J. Invest. Dermatol. 115, 149\u2013153 (2000).","journal-title":"J. Invest. Dermatol."},{"key":"8061_CR49","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa2019380","volume":"384","author":"T Bieber","year":"2021","unstructured":"Bieber, T. et al. Abrocitinib versus placebo or dupilumab for atopic dermatitis. N. Engl. J. Med. 384, 1101\u20131112 (2021).","journal-title":"N. Engl. J. Med."},{"key":"8061_CR50","doi-asserted-by":"publisher","first-page":"5323","DOI":"10.1093\/emboj\/cdg542","volume":"22","author":"AP Bracken","year":"2003","unstructured":"Bracken, A. P. et al. EZH2 is downstream of the pRB\u2013E2F pathway, essential for proliferation and amplified in cancer. EMBO J. 22, 5323\u20135335 (2003).","journal-title":"EMBO J."},{"key":"8061_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrrheum.2009.237","volume":"6","author":"JC Hall","year":"2010","unstructured":"Hall, J. C. & Rosen, A. Type I interferons: crucial participants in disease amplification in autoimmunity. Nat. Rev. Rheumatol. 6, 40\u201349 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"8061_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100951","volume":"37","author":"J Zhu","year":"2021","unstructured":"Zhu, J. et al. Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in patients treated with immune checkpoint inhibitors: A safety analysis of clinical trials and FDA pharmacovigilance database. eClinicalMedicine 37, 100951 (2021).","journal-title":"eClinicalMedicine"},{"key":"8061_CR53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1001\/jamadermatol.2023.5509","volume":"160","author":"PA Ireland","year":"2024","unstructured":"Ireland, P. A., Jansson, N., Spencer, S. K. R., Braden, J. & Sebaratnam, D. Short-term cardiovascular complications in dermatology patients receiving JAK-STAT inhibitors: a meta-analysis of randomized clinical trials. JAMA Dermatol. 160, 281\u2013289 (2024).","journal-title":"JAMA Dermatol."},{"key":"8061_CR54","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","volume":"386","author":"SR Ytterberg","year":"2022","unstructured":"Ytterberg, S. R. et al. Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N. Engl. J. Med. 386, 316\u2013326 (2022).","journal-title":"N. Engl. J. Med."},{"key":"8061_CR55","doi-asserted-by":"publisher","first-page":"100643","DOI":"10.1016\/j.mcpro.2023.100643","volume":"22","author":"TM Nordmann","year":"2023","unstructured":"Nordmann, T. M. et al. A standardized and reproducible workflow for membrane glass slides in routine histology and spatial proteomics. Mol. Cell Proteomics 22, 100643 (2023).","journal-title":"Mol. Cell Proteomics"},{"key":"8061_CR56","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","volume":"19","author":"M Pachitariu","year":"2022","unstructured":"Pachitariu, M. & Stringer, C. Cellpose 2.0: how to train your own model. Nat. Methods 19, 1634\u20131641 (2022).","journal-title":"Nat. Methods"},{"key":"8061_CR57","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","volume":"17","author":"F Meier","year":"2020","unstructured":"Meier, F. et al. diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition. Nat. Methods 17, 1229\u20131236 (2020).","journal-title":"Nat. Methods"},{"key":"8061_CR58","doi-asserted-by":"publisher","first-page":"e10798","DOI":"10.15252\/msb.202110798","volume":"18","author":"AD Brunner","year":"2022","unstructured":"Brunner, A. D. et al. Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation. Mol. Syst. Biol. 18, e10798 (2022).","journal-title":"Mol. Syst. Biol."},{"key":"8061_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"8061_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01486-0","volume":"22","author":"M Al Tarrass","year":"2024","unstructured":"Al Tarrass, M. et al. Large-scale phosphoproteomics reveals activation of the MAPK\/GADD45beta\/P38 axis and cell cycle inhibition in response to BMP9 and BMP10 stimulation in endothelial cells. Cell Commun. Signal. 22, 158 (2024).","journal-title":"Cell Commun. Signal."},{"key":"8061_CR61","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W Walter","year":"2015","unstructured":"Walter, W., Sanchez-Cabo, F. & Ricote, M. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics 31, 2912\u20132914 (2015).","journal-title":"Bioinformatics"},{"key":"8061_CR62","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1074\/mcp.TIR118.000943","volume":"18","author":"K Krug","year":"2019","unstructured":"Krug, K. et al. A curated resource for phosphosite-specific signature analysis. Mol. Cell Proteomics 18, 576\u2013593 (2019).","journal-title":"Mol. Cell Proteomics"},{"key":"8061_CR63","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","volume":"47","author":"Y Liao","year":"2019","unstructured":"Liao, Y., Wang, J., Jaehnig, E. J., Shi, Z. & Zhang, B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 47, W199\u2013W205 (2019).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08061-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T13:08:09Z","timestamp":1732712889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-024-08061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,16]]},"references-count":63,"journal-issue":{"issue":"8040","published-print":{"date-parts":[[2024,11,28]]}},"alternative-id":["8061"],"URL":"https:\/\/doi.org\/10.1038\/s41586-024-08061-0","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,16]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A patent for treatment of TEN, SJS\u2013TEN and SJS with JAKi has been filed (US patent: provisional application no. 63\/531,677; European patent: provisional application no. 23 190 686.8, with T.M.N., L.E.F. and M.M. as inventors). The patent application belongs to the Max-Planck-Gesellschaft zur F\u00f6rderung der Wissenschaften e.V. M.M. is an indirect investor in Evosep Biosystems. The authors declare no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}